September 29, 2016 9:36 PM ET

Healthcare Equipment and Supplies

Company Overview of New Health Sciences Inc.

Company Overview

New Health Sciences Inc. develops blood storage systems. Its product, Hemanext is an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers a more physiologic, therapeutic, and fresher red blood cell than conventional storage systems. The company’s Hemanext comprises a filter and an anaerobic storage bag. New Health Sciences Inc. was formerly known as New Health Systems Inc. The company was founded in 2000 and is based in Cambridge, Massachusetts.

245 First Street

Suite 1800

Cambridge, MA 02142

United States

Founded in 2000

Phone:

301-493-5550

Fax:

301-493-4360

Key Executives for New Health Sciences Inc.

Chief Executive Officer, President and Director
Vice President of Finance and Administration
Director of Research & Development
Vice President of Research and Clinical Affairs
Vice President of Product Development
Compensation as of Fiscal Year 2016.

New Health Sciences Inc. Key Developments

New Health Sciences Inc. Awards $3 Million NIH Grant to Commercialize Hemanext

New Health Sciences Inc. announced that it has been awarded an SBIR Phase IIB Bridge Grant by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health. The award provides $3 million in funding over 3 years to complete the product development and clinical work required to commercialize Hemanext, NHSi's novel gas optimized storage system for donated red blood cells. SBIR (Small Business Innovation Research) Phase IIB grants are intended to support companies through their last stages of R&D before commercialization. Only previous SBIR Phase II grant recipients are eligible to apply and winners must submit a viable Commercialization plan, including commitments from independent third party funding sources to match or exceed the NIH funds awarded. This award was granted under solicitation Funding Opportunity Announcement (FOA) RFA-HL-16-009 and follows earlier grants and contracts from the NIH providing $3.8 million. In the US, 5 million patients receive blood transfusions every year for everything from traumatic bleeding to oncology related anemia to inherited diseases such as sickle cell disease. Blood transfusions save and sustain thousands of lives every day, but studies have shown that transfused blood, particularly in large volumes and to vulnerable patients can increase the risk of infections, adverse events and death. The deterioration that occurs in red blood cells during storage is well established and may hold the potential for harm especially at the end of storage life. New research is also revealing wide variations in the storage characteristics of blood from different donors.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact New Health Sciences Inc., please visit newhealthsciences.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.